Figures & data
Table 1. The distribution of the main clinicopathological characteristics of hidradenocarcinoma patients.
Figure 1. (A) Overall survival (OS) and cancer-specific survival (CSS) of hidradenocarcinoma patients. (B) Overall survival (OS) and cancer-specific survival (CSS) of hidradenocarcinoma patients stratified by primary site.
![Figure 1. (A) Overall survival (OS) and cancer-specific survival (CSS) of hidradenocarcinoma patients. (B) Overall survival (OS) and cancer-specific survival (CSS) of hidradenocarcinoma patients stratified by primary site.](/cms/asset/d322e870-3b90-4f85-a35a-76913da3d67b/iann_a_2032313_f0001_c.jpg)
Table 2. Survival rates of hidradenocarcinoma patients stratified by primary site.
Figure 2. Overall survival (OS) of hidradenocarcinoma patients stratified by sex, race, histologic grade, American Joint Committee on Cancer (AJCC) stage, and primary site surgery.
![Figure 2. Overall survival (OS) of hidradenocarcinoma patients stratified by sex, race, histologic grade, American Joint Committee on Cancer (AJCC) stage, and primary site surgery.](/cms/asset/3b0428aa-e72c-4a6f-9185-5f9d69af947d/iann_a_2032313_f0002_c.jpg)
Figure 3. Cancer-specific survival (CSS) of hidradenocarcinoma patients stratified by sex, race, histologic grade, American Joint Committee on Cancer (AJCC) stage, and primary site surgery.
![Figure 3. Cancer-specific survival (CSS) of hidradenocarcinoma patients stratified by sex, race, histologic grade, American Joint Committee on Cancer (AJCC) stage, and primary site surgery.](/cms/asset/27a0ea25-ef8e-4efa-b1f9-8f68084d030b/iann_a_2032313_f0003_c.jpg)
Figure 4. Overall survival (OS) and cancer-specific survival (CSS) of hidradenocarcinoma patients stratified by tumour size and age.
![Figure 4. Overall survival (OS) and cancer-specific survival (CSS) of hidradenocarcinoma patients stratified by tumour size and age.](/cms/asset/f711bb5d-e8e7-4c10-b931-055a23bda070/iann_a_2032313_f0004_c.jpg)
Table 3. Univariable survival analysis of hidradenocarcinoma patients.
Table 4. Univariable survival analysis of hidradenocarcinoma patients stratified by primary site.
Data availability statement
The datasets generated during the present study are available in the official software. SEER* Stat version 8.3.9.1 repository (https://seer.cancer.gov/data/).